Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Venture Global on behalf of The Partnership for Safe Medicines
Lobbying Relationship
Bills mentioned
H.R.447: Affordable and Safe Prescription Drug Importation Act
Sponsor: Elijah E. Cummings (D-Md.)
H.R.478: Safe and Affordable Drugs from Canada Act of 2019
Sponsor: Chellie Pingree (D-Maine)
S.61: Safe and Affordable Drugs from Canada Act of 2019
Sponsor: Charles E. Grassley (R-Iowa)
S.97: Affordable and Safe Prescription Drug Importation Act
Sponsor: Bernard Sanders (ID-Vt.)
S.1801: Affordable Medications Act
Sponsor: Tina Smith (D-Minn.)
H.R.4510: Criminalizing Abused Substance Templates Act of 2019
Sponsor: David Kustoff (R-Tenn.)
S.954: POWER Act
Sponsor: Sherrod Brown (D-Ohio)
H.R.2070: POWER Act
Sponsor: Conor Lamb (D-Pa.)
S.400: Blocking Deadly Fentanyl Imports Act
Sponsor: Patrick J. Toomey (R-Pa.)
H.R.1098: Blocking Deadly Fentanyl Imports Act
Sponsor: F. James Sensenbrenner (R-Wis.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Nicole Semenza | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate